Valuation Gennex Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:29:33 2026-08-17 EDT			5-day change	1st Jan Change
12.00 ^INR	+10.91%		+34.08%	-16.08%

08-14	Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Gennex Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	235.3	494.6	952.6	1,004	3,594	2,741
Change	-	110.22%	92.58%	5.42%	257.85%	-23.73%
Enterprise Value (EV) ¹	283	566.5	978.9	1,036	3,181	2,466
Change	-	100.18%	72.81%	5.79%	207.16%	-22.47%
P/E	12.7x	12.3x	24.3x	16.7x	26x	15.4x
PBR	0.66x	1.25x	2.17x	1.23x	2.11x	1.47x
PEG	-	0x	-8.74x	1.94x	0.3x	0.5x
Capitalization / Revenue	0.42x	0.82x	1.56x	1.53x	4.14x	1.99x
EV / Revenue	0.5x	0.94x	1.6x	1.58x	3.67x	1.79x
EV / EBITDA	7.23x	8.03x	17.9x	20.8x	18.3x	14.5x
EV / EBIT	9.73x	9.18x	20.9x	25.6x	21.2x	16.4x
EV / FCF	-38.4x	-20.6x	32.8x	-5.89x	-6.22x	-9.86x
FCF Yield	-2.61%	-4.86%	3.05%	-17%	-16.1%	-10.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.1467	0.319	0.3101	0.3369	0.608	0.783
Distribution rate	-	-	-	-	-	-
Net sales ¹	562.3	600.4	612.1	656	867.1	1,379
EBITDA ¹	39.12	70.53	54.76	49.7	173.9	170.4
EBIT ¹	29.07	61.72	46.88	40.51	150.2	150.5
Net income ¹	18.56	40.38	39.23	49.21	131.8	181.2
Net Debt ¹	47.68	71.83	26.33	31.28	-412.9	-274.8
Reference price ²	1.86	3.91	7.53	5.61	15.80	12.05
Nbr of stocks (in thousands)	126,503	126,503	126,503	179,010	227,448	227,448
Announcement Date	9/6/20	9/8/21	9/9/22	9/9/23	9/7/24	9/8/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENNEX LABORATORIES LIMITED	-	-	-	-	27.49M
ELI LILLY AND COMPANY	33.76x	12.18x	24.85x	0.59%	1,052B
JOHNSON & JOHNSON	28.96x	-	-	2.06%	627B
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	441B
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	349B
NOVARTIS AG	21.42x	5.54x	13.77x	2.89%	287B
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	241B
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	224B
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	202B
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	172B
Average	17.00x	6.46x	15.43x	2.43%	359.52B
Weighted average by Cap.	24.17x	8.04x	17.73x	2%